000 04900nam a22004335i 4500
999 _c11365
_d11365
001 11365
003 DE-He213
005 20210706040349.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180627s2018 gw | s |||| 0|eng d
020 _a9783319765938
024 7 _a10.1007/978-3-319-76593-8
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 _aR727.43
_b.D78 2018 EB
090 4 _aRC681-688.2
245 0 0 _aDrug Adherence in Hypertension and Cardiovascular Protection
_cedited by Michel Burnier.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _a1 recurso en línea ( VIII, 314 páginas 43 ilustraciones, 30 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 1 _aUpdates in Hypertension and Cardiovascular Protection
_x2366-4606
490 _aMedicine (Springer-11650)
505 0 _a1 Taxonomy of adherence -- I Measuring drug adherence -- 2 Qualitative assessment of adherence -- 3 Electronic monitoring of drug adherence -- 4 Measurements of drugs in plasma/urine -- 5 Assessing adherence measurement in large databases -- 6 Direct observed treatment in hypertension -- 7 Novel technologies for following drug adherence -- 8 Ethical aspects of measuring adherence II Risk factors for non-adherence -- 9 Determinants and barriers to adherence in CV diseases -- 10 Beliefs and adherence -- III Adherence in hypertension and CV protection -- 11 Impact of drug adherence in clinical trials -- 12 Drug adherence in essential hypertension: impact of drugs -- 13 Persistence in hypertension in general practice -- 14 Drug adherence in resistant hypertension -- 15 Drug adherence with cardiovascular medicines (statins) -- 16 Adherence and cardiovascular risk -- IV Interventions to improve drug adherence -- 17 Which interventions are useful? -- 18 Use of fixed-dose combinations in CV disease prevention -- 19 Nurse-led intervention in Hypertension -- 20 Role of the Pharmacist in supporting adherence -- 21 Integrated approaches to support adherence -- 22 Use of Apps to improve drug adherence -- V Health care consequences of non-adherence -- 23 Global clinical consequence of poor adherence -- 24 Cost of non-adherence.
520 _aThis book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence. The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases.
988 _aEBSPRINGER_MEDICINA_FEB2019
650 7 _2embne
_9159154
_aCumplimiento terapéutico
650 7 _2embne
_9169667
_aCorazón
_xEnfermedades
700 1 _aBurnier, Michel
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/n81065180
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_9106996
776 0 8 _iPrinted edition:
_z9783319765921
776 0 8 _iPrinted edition:
_z9783319765945
776 0 8 _iPrinted edition:
_z9783030095284
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-76593-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_zSI